SCHEMBL27384342

SCHEMBL27384342

CC(C)c1cc2[nH]c(CNC(=O)N3CCCOC3)cc2cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF4A3 P38919 1/20 0.42
▸ MAPK1 P28482 5/20 0.38
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ HRH3 Q9Y5N1 2/20 0.33
▸ CHRNA7 P36544 3/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384655 0.89 EIF4A3 (0.48) EIF4A3MAPK1KDM4EMEN1ALDH1A1
SCHEMBL27384648 0.89 EIF4A3 (0.48) EIF4A3MAPK1KDM4EMEN1ALDH1A1
SCHEMBL27384340 0.88 EIF4A3 (0.47) EIF4A3MAPK1KDM4EMEN1ALDH1A1
SCHEMBL27384348 0.81 EIF4A3 (0.46) EIF4A3MAPK1RAB9ANPC1HRH3
SCHEMBL27384352 0.81 EIF4A3 (0.49) EIF4A3MAPK1KDM4ERAB9ANPC1
SCHEMBL27384339 0.77 MAPK1 (0.42) EIF4A3MAPK1KDM4EMEN1ALDH1A1
SCHEMBL27384346 0.77 EIF4A3 (0.45) EIF4A3MAPK1ALDH1A1HSD17B10RAB9A
SCHEMBL27384854 0.77 MAPK1 (0.41) MAPK1KDM4EMEN1ALDH1A1MAPT
SCHEMBL27382678 0.77 EIF4A3 (0.56) EIF4A3KDM4EALDH1A1MAPTHSD17B10
SCHEMBL27382556 0.76 EIF4A3 (0.54) EIF4A3KDM4ERAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback